Access & reimbursement

Prostate Cancer Treatment Is Creating a Metabolic Bill

Parkinson’s Gets a Cleaner Dopamine Bet

Endometrial Cancer Prehab Should Not Be a Luxury Experiment

Do patients need maximum-dose tirzepatide forever? New data suggest a middle ground

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

Duchenne’s Cell Therapy Gets More Time, Not Certainty

Radiopharmaceuticals Just Got a Necessary No

Alzheimer’s Blood Tests Are Becoming the Gate

WHO Rewrote the Typhoid Playbook
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
